
ProShares UltraPro Short QQQ, PepsiCo, Chevron, Southern, AT&T, Pfizer, and Vale are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that regularly distribute part of their earnings to shareholders, usually as cash payments called dividends. Investors may buy them for income as well as potential share-price gains, but dividends can be reduced or stopped, and the stock’s value can fall. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
NASDAQ:SQQQ traded up $3.03 during trading hours on Monday, hitting $45.49. 40,797,699 shares of the company were exchanged, compared to its average volume of 56,008,512. ProShares UltraPro Short QQQ has a 52-week low of $31.42 and a 52-week high of $90.71. The company’s 50 day moving average price is $37.83 and its 200-day moving average price is $49.11.
Read Our Latest Research Report on SQQQ
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
Shares of NASDAQ:PEP traded up $1.06 during trading on Monday, hitting $146.50. The stock had a trading volume of 4,755,107 shares, compared to its average volume of 8,249,028. PepsiCo has a 12-month low of $123.47 and a 12-month high of $171.48. The stock has a market capitalization of $199.65 billion, a price-to-earnings ratio of 18.40, a price-to-earnings-growth ratio of 4.33 and a beta of 0.31. The company has a quick ratio of 0.76, a current ratio of 0.94 and a debt-to-equity ratio of 1.90. The stock has a 50-day simple moving average of $133.64 and a two-hundred day simple moving average of $145.68.
Read Our Latest Research Report on PEP
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
NYSE CVX traded down $2.35 during trading hours on Monday, reaching $217.54. The stock had a trading volume of 3,015,987 shares, compared to its average volume of 10,195,422. Chevron has a 52-week low of $146.49 and a 52-week high of $236.48. The stock has a fifty day moving average of $215.49 and a 200 day moving average of $195.58. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.07 and a current ratio of 1.34. The stock has a market cap of $427.55 billion, a P/E ratio of 15.92, a price-to-earnings-growth ratio of 0.51 and a beta of 0.47.
Read Our Latest Research Report on CVX
Southern (SO)
The Southern Company, through its subsidiaries, engages in the generation, transmission, and distribution of electricity. The company also develops, constructs, acquires, owns, and manages power generation assets, including renewable energy projects and sells electricity in the wholesale market; and distributes natural gas in Illinois, Georgia, Virginia, and Tennessee, as well as provides gas marketing services, gas distribution operations, and gas pipeline investments operations.
SO traded up $1.00 during trading on Monday, reaching $94.59. 6,453,246 shares of the company’s stock were exchanged, compared to its average volume of 6,045,855. The company has a debt-to-equity ratio of 1.55, a current ratio of 0.84 and a quick ratio of 0.62. Southern has a 1 year low of $81.69 and a 1 year high of $99.58. The company’s fifty day simple moving average is $88.67 and its 200-day simple moving average is $92.61. The stock has a market capitalization of $110.13 billion, a P/E ratio of 21.53, a price-to-earnings-growth ratio of 4.01 and a beta of 0.30.
Read Our Latest Research Report on SO
AT&T (T)
AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally.
Shares of NYSE:T traded up $0.14 during midday trading on Monday, reaching $22.32. The company’s stock had a trading volume of 21,462,222 shares, compared to its average volume of 48,621,570. The firm has a market capitalization of $150.39 billion, a PE ratio of 12.05, a P/E/G ratio of 1.10 and a beta of 0.30. AT&T has a twelve month low of $19.89 and a twelve month high of $29.43. The stock has a fifty day moving average of $23.57 and a 200 day moving average of $24.88. The company has a quick ratio of 0.82, a current ratio of 0.87 and a debt-to-equity ratio of 1.22.
Read Our Latest Research Report on T
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
NYSE PFE traded up $0.08 on Monday, reaching $28.97. 15,928,695 shares of the company’s stock traded hands, compared to its average volume of 39,623,063. The firm has a market cap of $165.10 billion, a price-to-earnings ratio of 41.31, a P/E/G ratio of 1.90 and a beta of 0.31. The stock has a 50 day moving average price of $28.80 and a 200-day moving average price of $26.98. Pfizer has a fifty-two week low of $23.62 and a fifty-two week high of $31.44. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.10 and a current ratio of 1.42.
Read Our Latest Research Report on PFE
Vale (VALE)
Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally. The company operates through Iron Solutions and Energy Transition Materials segments. The Iron Solutions segment produces and extracts iron ore and pellets, manganese, and other ferrous products; and provides related logistic services.
NYSE:VALE traded down $0.68 during mid-day trading on Monday, hitting $10.54. The company’s stock had a trading volume of 42,400,689 shares, compared to its average volume of 30,535,795. The business’s fifty day moving average is $13.13 and its two-hundred day moving average is $15.05. The stock has a market cap of $47.84 billion, a price-to-earnings ratio of 70.30 and a beta of 0.50. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.10 and a quick ratio of 0.71. Vale has a 1 year low of $10.48 and a 1 year high of $17.94.
Read Our Latest Research Report on VALE
Further Reading
- MarketBeat’s Top Five Stocks to Own in November 2026
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
